Tuesday, 21 May 2024 03:38 AM
OR
Login using
Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe
June 23, 2021 19:00 pm
BRUSSELS, June 23: At the height of Europe's vaccine supply crisis in March, Johnson & Johnson's (J&J) single-dose COVID-19 vaccine was touted as a game-changer. But two months into its rollout, the shot has the lowest uptake of all four approved vaccines.
Trending
Just In
- Airlines except Tara air halt flights on Ramechhap-Lukla route with mountain climbing season drawing to a close
- NC Vice President Gurung writes letter to Speaker demanding action against Home Minister Lamichhane
- Man-eater tiger dies in Sauraha
- Mayor Balen announces 101 companies attempting land swaps like Giri Bandhu Tea Estate
- CAAN Director General Adhikari to take part in Future Aviation Forum
- Nepal seeks repatriation of 15th century Buddha statue stolen by Chinese smugglers
- Nepal expresses grief over passing of Iranian president, foreign minister in tragic helicopter accident
- NEPSE surges 27.54 points, daily turnover rises to Rs 5.85 billion